Reduction of the rocuronium-induced withdrawal reflex by MR13A10A, a generic rocuronium with a novel solution: A randomized, controlled study
Autoři:
Masaru Shimizu aff001; Fumimasa Amaya aff002; Mao Kinoshita aff001; Masaki Yamasaki aff001; Isao Yokota aff003; Teiji Sawa aff001
Působiště autorů:
Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan
aff001; Department of Pain Management and Palliative Care Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
aff002; Department of Biostatistics, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
aff003
Vyšlo v časopise:
PLoS ONE 14(10)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0223947
Souhrn
Background
Rocuronium induces venous pain and the withdrawal reflex during injection. MR13A10A, generic rocuronium with a novel solution, reduced the injection-induced withdrawal reflex in rodents. We hypothesized that MR13A10A would reduce the frequency and severity of injection-induced withdrawal reflexes compared with original rocuronium during clinical anesthesia induction.
Methods
This prospective, open (but assessor-blinded), randomized, controlled study was conducted at a single academic hospital. The assessor was blinded to the study condition in order to minimize observer bias. Participants were allocated to either MR13A10A or traditional formula groups by a blocked stratified randomization method. Participants in the MR13A10A group received MR13A10A, whereas the original rocuronium group received the same amount of original rocuronium. The primary outcome was presence of the withdrawal reflex after rocuronium injection. Severity of the withdrawal reflex, changes in blood pressure and heart rate, and the train of four (TOF) ratio were measured as secondary outcomes. The withdrawal reflex was assessed using a video recording in a blinded manner.
Results
Of the 149 participants, 76 were allocated to the MR13A10A group and 73 to the original rocuronium group. The frequency of the withdrawal reflex was significantly lower with MR13A10A compared with original rocuronium (19.7% and 54.8% for MR13A10A and original rocuronium groups, respectively, p<0.001). The odds ratio adjusted for cannulation site, cannula size, induction agent and age was 6.27 (95% CI, 2.87, 13.73 p<0.001). Original rocuronium was an independent factor related to a higher post-treatment heart rate. The proportions of TOF ratios = 0 were similar between the two groups.
Conclusion
The frequency and severity of the withdrawal reflex after injection were significantly reduced by using MR13A10A. MR13A10A might contribute to safe and less invasive anesthesia management.
Klíčová slova:
Blood pressure – Hemodynamics – Heart rate – Japan – Anesthesia – Reflexes – General anesthesia
Zdroje
1. Oda Y. Rocuronium bromide: clinical application of single-dose pharmacokinetic models to continuous infusion. J Anesth. 2018;32(1):1–2. doi: 10.1007/s00540-017-2401-8 28828750
2. Steegers MA, Robertson EN. Pain on injection of rocuronium bromide. Anesth Analg. 1996;83(1):203.
3. Moorthy SS, Dierdorf SF. Pain on injection of rocuronium bromide. Anesth Analg. 1995;80(5):1067.
4. Lockey D, Coleman P. Pain during injection of rocuronium bromide. Anaesthesia. 1995;50(5):474.
5. Borgeat A, Kwiatkowski D. Spontaneous movements associated with rocuronium: is pain on injection the cause? British journal of anaesthesia. 1997;79(3):382–3. doi: 10.1093/bja/79.3.382 9389860
6. Mencke T, Beerhalter U, Fuchs-Buder T. Spontaneous movements, local reactions and pain on injection of rocuronium. A comparison between female and male patients. Acta Anaesthesiol Scand. 2001;45(8):1002–5. doi: 10.1034/j.1399-6576.2001.450813.x 11576052
7. Mahajan C, Rath GP, Bithal PK, Prabhakar H, Yadav R, Dube SK. Local warming at injection site helps alleviate pain after rocuronium administration. J Anesth. 2010;24(6):845–8. doi: 10.1007/s00540-010-1014-2 20737278
8. Memis D, Turan A, Karamanlioglu B, Sut N, Pamukcu Z. The prevention of pain from injection of rocuronium by ondansetron, lidocaine, tramadol, and fentanyl. Anesth Analg. 2002;94(6):1517–20, table of contents. doi: 10.1097/00000539-200206000-00026 12032018
9. Shevchenko Y, Jocson JC, McRae VA, Stayer SA, Schwartz RE, Rehman M, et al. The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents. Anesth Analg. 1999;88(4):746–8. doi: 10.1097/00000539-199904000-00011 10195516
10. Kim SJ, Lee HY, An TH. Comparison of Withdrawal Responses Associated with Temperature and Gender on the Injection of Rocuronium. Korean J Anesthesiol. 2004;47(3):331–5.
11. Shin YH, Kim CS, Lee JH, Sim WS, Ko JS, Cho HS, et al. Dilution and slow injection reduces the incidence of rocuronium-induced withdrawal movements in children. Korean J Anesthesiol. 2011;61(6):465–9. doi: 10.4097/kjae.2011.61.6.465 22220222
12. Oh AY, Seo KS, Goo EK, Park YO, Kim SJ, Kim JH. Prevention of withdrawal movement associated with injection of rocuronium in children: comparison of remifentanil, alfentanil and fentanyl. Acta Anaesthesiol Scand. 2007;51(9):1190–3. doi: 10.1111/j.1399-6576.2007.01371.x 17711566
13. Ahmad N, Choy CY, Aris EA, Balan S. Preventing the withdrawal response associated with rocuronium injection: a comparison of fentanyl with lidocaine. Anesth Analg. 2005;100(4):987–90. doi: 10.1213/01.ANE.0000147790.76114.3A 15781511
14. Shin YH, Choi SJ, Jeong HY, Kim MH. Evaluation of dose effects of magnesium sulfate on rocuronium injection pain and hemodynamic changes by laryngoscopy and endotracheal intubation. Korean journal of anesthesiology. 2011;60(5):329–33. doi: 10.4097/kjae.2011.60.5.329 21716962
15. Kwak HJ, Kim JY, Kim YB, Min SK, Moon BK, Kim JY. Pharmacological prevention of rocuronium-induced injection pain or withdrawal movements: a meta-analysis. J Anesth. 2013;27(5):742–9. doi: 10.1007/s00540-013-1595-7 23519582
16. Liou JT, Hsu JC, Liu FC, Ching-Wah Sum D, Lui PW. Pretreatment with small-dose ketamine reduces withdrawal movements associated with injection of rocuronium in pediatric patients. Anesth Analg. 2003;97(5):1294–7. doi: 10.1213/01.ane.0000082247.39704.79 14570640
17. Jimbo K, Itsuji Y, MItani O, Nagahara H, Kubo E, Kumagai M, et al. The Generic Rocuronium formulation reduced inection pain. Japanese Pharmacol Ther. 2017;45(3):385–93.
18. Jimbo K, Itsuji Y, Kubo E, Kumagai M, Masui K, Yamamura Y. A new rocuronium formulation not causing vascular pain in a flexor reflex model of anesthetized rats. J Anesth. 2018.
19. Jimbo K, Itsuji Y, Kubo E, Kumagai M, Masui K, Yamamura Y. A new rocuronium formulation not causing vascular pain in a flexor reflex model of anesthetized rats. J Anesth. 2018.
20. Yilmaz S, Hatiboglu Y. The evaluation of the effect of venous diameter measurement by ultrasonography on pain and withdrawal response. J Anesth. 2018;32(3):375–80. doi: 10.1007/s00540-018-2489-5 29572726
21. Zhang XM, Wang Q, Wang WS, Wang M. Large vein injection alleviates rocuronium-induced pain in gynaecologic patients. Anaesth Crit Care Pain Med. 2017;36(4):233–5. doi: 10.1016/j.accpm.2016.03.010 27485805
22. Blunk JA, Seifert F, Schmelz M, Reeh PW, Koppert W. Injection pain of rocuronium and vecuronium is evoked by direct activation of nociceptive nerve endings. Eur J Anaesthesiol. 2003;20(3):245–53. doi: 10.1017/s0265021503000413 12650497
23. Tuncali B, Karci A, Tuncali BE, Mavioglu O, Olguner CG, Ayhan S, et al. Dilution of rocuronium to 0.5 mg/mL with 0.9% NaCl eliminates the pain during intravenous injection in awake patients. Anesthesia and analgesia. 2004;99(3):740–3, table of contents. doi: 10.1213/01.ANE.0000130005.94395.B2 15333404
24. Chiarella AB, Jolly DT, Huston CM, Clanachan AS. Comparison of four strategies to reduce the pain associated with intravenous administration of rocuronium. Br J Anaesth. 2003;90(3):377–9. doi: 10.1093/bja/aeg054 12594153
25. Park JT, Choi JC, Yoo YS, Lee YB, Kim SY, Lim HK. The effect of pretreatment with thiopental on reducing pain induced by rocuronium injection. Yonsei Med J. 2005;46(6):765–8. doi: 10.3349/ymj.2005.46.6.765 16385651
26. Park SH, Oh AY, Goo EK, Nahm FS, Min SW, Hwang JW, et al. A short period of inhalation induction with sevoflurane prevents rocuronium-induced withdrawal in children. Acta Anaesthesiol Scand. 2011;55(1):87–91. doi: 10.1111/j.1399-6576.2010.02317.x 21126238
Článok vyšiel v časopise
PLOS One
2019 Číslo 10
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Eliquis (apixaban) nově hrazen ze zdravotního pojištění
Najčítanejšie v tomto čísle
- Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
- Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
- Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis
- Prevalence of pectus excavatum (PE), pectus carinatum (PC), tracheal hypoplasia, thoracic spine deformities and lateral heart displacement in thoracic radiographs of screw-tailed brachycephalic dogs